What exciting times! Clinical trials into the management of SAB! SNAP publication on the horizon!

But how do we interpret and apply the results of these trials to our patients? This week Jame and Callum are joined by Dr Clark Russell, Clinical Lecturer in Infectious Diseases to discuss:

The difficulty in interpreting current clinical trials in SAB.
The emerging concept of "low risk" SAB and how to define this.
The heterogeneity of SAB and how this might be exploited.

Notes for this episode here: https://idiots.notion.site/107-SAB-update-1316a1ea09d8800ba701ca7ebc8d4093

Previous episodes for the basics of Staphylococcus aureus and SABATO & SNAP trials:

1. It starts with Staph

65. SNAP trial protocol

72. SABATO trial & 73. SABATaddendum

Support the show

Questions, comments, suggestions to idiotspodcasting@gmail.com or on Bluesky @idiots-pod.bsky.social

Prep notes for completed episodes can be found here (Not all episodes have prep notes).

If you are enjoying the podcast please leave a review on your preferred podcast app!

Feel like giving back? Donations of caffeine gratefully received!
https://www.buymeacoffee.com/idiotspod

107. Staphylococcus aureus bacteraemia (SAB) - interpreting and applying the literature

ID:IOTS - Infectious Disease Insight Of Two Specialists